Clinical trial
Inhaled Morphine Compared With Morphine By Mouth in Treating Cancer Patients…
NCT00020618 · Dana-Farber Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00020618 |
|---|---|
| Title | Inhaled Morphine Compared With Morphine By Mouth in Treating Cancer Patients With Breakthrough Pain |
| Official title | An Open Label, Randomized, Multicenter, Crossover, Phase II Study to Compare Pain Relief Following Morphine Administration Via AERxPMS vs Orally in Cancer Patients Experiencing Opioid-Sensitive Breakthrough Pain |
| Lead sponsor | Dana-Farber Cancer Institute, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pain, Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug, Procedure |
| Interventions | morphine sulfate, quality-of-life assessment |
| Start date | Mar 1, 2001 |
| Completion | Feb 1, 2004 |
| First posted | Feb 27, 2004 |
| Last update posted | Jul 18, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: